~~<i id='624C0023B8'><strike id='624C0023B8'><tt id='624C0023B8'><pre id='624C0023B8'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

entertainment

author：entertainment 2025-09-28 21:06:11 - browse：8314

It is one of health care’s most vexing quandaries: Patient data must be shared to develop more effective medicines and artificial intelligence tools, but there’s no way to share it without violating privacy and basic data rights.

Or is there?

A fresh crop of companies is building a new data economy that enables the shared use of personal health information while enforcing ironclad privacy protections. They are not a monolithic group: each one uses its own methods and technologies, serves different customers, and is motivated by distinct problems and personal philosophies.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Cue Health's Covid

knowledge

hotspot

entertainment

focus

hotspot

Wikipedia

Wanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyourinb

WSS

Why rehabilitation engineers need to center patients in their research

Orangutan used medicinal plant to treat wound, first time ever seen

Medical bills so high, Medicare adding extra digits to claim forms

The most pressing bird flu mysteries scientists want answered

Congress needs to close a vaccine

Cholera vaccine supply gets boost as demand surges globally

knowledge

entertainment

knowledge

In Memoriam: Notable people who died in 2023

Exact Sciences stock tumbles despite strong cancer detection sales

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Why does health care cost so much? A reading guide

Sports medicine is finally prioritizing gender equality

MultiPlan and major insurers sued for alleged medical price

Hepatitis C has a cure — but many Americans still lack access to it

Structure Therapeutics oral GLP

FDA approval of Sarepta Duchenne genetic therapy gives me hope

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

hotspot

MassMutual is introducing free genetic testing for members

How CO2 helps viruses stay alive longer in the air

Illumina board agrees to spin off Grail, as divestment plans proceed

Sutter Health’s antitrust win overturned by appeals court

Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

Cell therapy fails to slow type 1 diabetes, but safety is established

entertainment

focus

hotspot

Wikipedia